Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine

Devis Benfaremo1,2, Silvia Agarbati1, Matteo Mozzicafreddo1

  • 1Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.

Insights

Systemic sclerosis (SSc) presents diverse patient responses, complicating clinical trials. Analyzing skin gene expression can identify patient subgroups for personalized treatments, advancing precision medicine in SSc management.

Area of Science:

  • Computational biology
  • Genomics
  • Dermatology

Background:

  • Systemic sclerosis (SSc), or scleroderma, exhibits significant heterogeneity in clinical presentation, disease progression, and treatment response.
  • This heterogeneity poses challenges for designing effective clinical trials to identify therapeutic interventions.
  • Recent advances in molecular profiling and stratification techniques offer potential for personalized treatment strategies.

Purpose of the Study:

  • To review the current state of skin gene expression analysis in SSc using computational biology.
  • To highlight the advantages of stratifying SSc patients based on their skin gene signatures.

Main Methods:

  • Narrative review of existing literature.
  • Focus on computational biology approaches for skin gene expression analysis.
  • Exploration of patient stratification techniques based on molecular profiles.

Main Results:

  • Skin gene expression analysis, coupled with computational biology, allows for the identification of distinct patient subgroups within SSc.
  • Stratification based on skin gene signatures can reveal patient subgroups amenable to specific therapeutic interventions.
  • This approach supports the development of personalized treatment strategies for SSc.

Conclusions:

  • Skin gene expression profiling and computational analysis are crucial for understanding SSc heterogeneity.
  • Patient stratification by gene signatures facilitates a precision medicine approach to SSc management.
  • This strategy holds promise for improving treatment efficacy and clinical trial design in SSc.